Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
AstraZeneca’s new U.S. spending also leaves in doubt the pharmaceutical company’s plans to invest in a vaccine site in ...
The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...
AstraZeneca said it is in China ‘for the long haul’ and outlined billions of pounds of investment in the US – but a new ...
On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
Zacks.com on MSN20h
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in USAstraZeneca’s AZN third-quarter 2024 core earnings of $1.04 per American depositary share (ADS) beat the Zacks Consensus ...
The Vancouver Sun on MSN17h
'John from Langford' was one of the most popular premiers in B.C. historyJohn Horgan was that rare politician who got more popular in office. He became B.C. premier in 2017 with a minority ...
Gone was “angry John,” the guy who couldn’t hide his frustration. In his place, “Premier Dad,” the happy warrior. Horgan is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback